Aldeyra Therapeutics Announces Positive Top-Line Symptom and Sign Results from Run-In Cohort of Phase 3 TRANQUILITY Trial in Dry Eye Disease …
Aldeyra Therapeutics: Bitte unbedingt beachten! http://www.aktiencheck.de/news/Artikel-Aldeyra_Therapeutics_Bitte_unbedingt_beachten-11604709